Skip to search formSkip to main contentSkip to account menu

RS 61443

Known as: RS-61443, RS61443 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
1997
1997
Inadequate vascularization and microvascular rejection are major limitations for successful free pancreatic islet… 
Review
1996
Review
1996
This review gives a summary about the current knowledge on the novel immunosuppressive drug mycophenolate mofetil (RS61443) in… 
Highly Cited
1995
Highly Cited
1995
Pharmacodynamic monitoring of the biological effect of immunosuppressive drugs provides an alternative to traditional therapeutic… 
1995
1995
Mycophenolate mofetil (MPM), a new immunosuppressant, is a morpholinoethyl ester of mycophenolic acid (MPA). The enzymatic and… 
Review
1994
Review
1994
It is believed that IgM xenoreactive natural antibodies (XNA) and activation of complement are the two main effectors involved in… 
1993
1993
The pharmacokinetics of mycophenolic acid (MPA) were investigated in six New Zealand white rabbits following (i.v.) and (s.c… 
1993
1993
In this study, the long-term effects of the immunosuppressive drug RS-61443 on pancreatic beta-cell function have been evaluated…